Key Takeaways Breakthrough Tech Synergy — TruLeaf’s nanotechnology pairs with TXTM’s kettle tech to dramatically increase CBD bioavailability, reduce costs, and improve patient outcomes. RWA Balance Sheet Innovation — TruLeaf-supported CBD API can be recognized as a real-world asset under IFRS/GAAP, strengthening net profit without cash outflow and enabling future stablecoin or staking applications. Regulatory & Market Advantage — TruLeaf’s THC-free FECO and Farm Bill compliance give TXTM...























